← Eichor
Study identifier: NCT06475456 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pilot Italian Cardiogenic Shock Initiative

Condition: Cardiogenic Shock  ·  Sponsor: Fondazione GISE Onlus

PhaseN/A
Planned participants786
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Study Objective To evaluate the impact on 30-day mortality of the adoption of a dedicated cardiogenic shock protocol designed to improve communication and collaboration among centres to timely refer Cardiogenic Shock (CS) patients from spoke to hub centres in Turin and Milan metropolitan Area. Study Design A multicentre, observational, study, consisting of * retrospective cohort including anonymous data from electronic health records of patients admitted with acute myocardial infarction complicated by cardiogenic shock (AMICS) SCAI class B-D, from Jan 2016 until Dec 2019 * prospective cohort including all consecutive patients admitted for AMICS SCAI class B-D in the study centres Study Population and Centres 768 patients admitted in spoke hospitals for AMICS: 384 in each study cohort. Four centres - two in Milan metropolitan Area and two in Turin - will serve as hub centres, each one receiving CS patients from three referring spoke centres. In total, 16 centres will be involved in the study. Follow-up period Up to 30 days from hospital admission Primary Endpoint The primary endpoint will be the short-term mortality defined as inhospital or 30-day mortality. Secondary Endpoints * In-hospital or 30-day incidence of: 1. stroke, (fatal or non-fatal) or TIA 2. bleedings (BARC classification ≥3), 3. renal replacement therapy (CVVH / new onset of dialysis) 4. vascular complications (all complication needing intervention), 5. non-fatal myocardial infarction * Door-to-supp…

This description comes directly from the study's public registry record.

Talk to the study team

Alaide Chieffo, Prof  ·  +390226437331  ·  cecalaide@gmail.com

Mario Iannaccone, MD  ·  +390112402851  ·  mario.iannaccone@hotmail.it

Always discuss trial participation with your own doctor first.

Locations (16)

Ospedale di ChivassoChivasso, ItalyRecruiting
ASL TO4 Ospedale di CirièCirié, ItalyRecruiting
Ospedale Pio XI di DesioDesio, ItalyRecruiting
ASL Torino 4 Ospedale di IvreaIvrea, ItalyRecruiting
ASST Grande Ospedale Metropolitano NiguardaMilan, ItalyRecruiting
ASST Nord MilanoMilan, ItalyRecruiting
IRCCS San RaffaeleMilan, ItalyRecruiting
Ospedale San Carlo BorromeoMilan, ItalyRecruiting
Ospedale San PaoloMilan, ItalyRecruiting
ASL TO5 Ospedale Santa CroceMoncalieri, ItalyRecruiting
Presidio Ospedaliero di RhoRho, ItalyRecruiting
Ospedale Civile SS. AnnunziataSavigliano, ItalyRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06475456